p.83 抽出テキスト

risks: Candesartan antihypertensive survival evaluation in Japan trial. Hypertension 2008; 51: 393-398. PMID: 18172059 88. Blood Pressure Lowering Treatment Trialists’ Collaboration. Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. J Hypertens 2007; 25: 951-958. PMID: 17414657 89. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs - overview and meta-analyses. J Hypertens 2015; 33: 1321-1341. PMID: 26039526 90. 日本動脈硬化学会.動脈硬化性疾患予防のための脂質異常症診療ガイド 2018年版.日本動脈硬化学会 2018. 91. Miida T, Nishimura K, Hirayama S, et al. Homogeneous Assays for LDL-C and HDL-C are Reliable in Both the Postprandial and Fasting State. J Atheroscler Thromb 2017; 24: 583-599. PMID: 28321014 92. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421. PMID: 12485966 93. Miida T, Otsuka H, Tsuchiya A, et al. Plasma lipoprotein profiles change significantly during cardiac catheterization. Clin Chem 1998; 44: 517-521. PMID: 9510856 94. Imamura T, Doi Y, Arima H, et al. LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population:The Hisayama study. Stroke 2009; 40: 382-388. PMID: 19095987 95. Imano H, Noda H, Kitamura A, et al. Low-density lipoprotein cholesterol and risk of coronary heart disease among Japanese men and women: The Circulatory Risk in Communities Study (CIRCS). Prev Med 2011; 52: 381-386. PMID: 21371493 96. Noda H, Iso H, Irie F, et al. Gender difference of association between LDL cholesterol concentrations and mortality from coronary heart disease amongst Japanese: the Ibaraki Prefectural Health Study. J Intern Med 2010; 267: 576-587. PMID: 20141564 97. Yokokawa H, Yasumura S, Tanno K, et al. Serum low-density lipoprotein to high-density lipoprotein ratio as a predictor of future acute myocardial infarction among men in a 2.7-year cohort study of a Japanese northern rural population. J Atheroscler Thromb 2011; 18: 89- 98. PMID: 20972352 98. Noda H, Iso H, Irie F, et al. Low-density lipoprotein cholesterol concentrations and death due to intraparenchymal hemorrhage: The Ibaraki Prefectural Health Study. Circulation 2009; 119: 2136-2145. PMID: 19364982 99. Okamura T, Kokubo Y, Watanabe M, et al. Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study. Atherosclerosis 2009; 203: 587-592. PMID: 18783774 100. Kodama K, Sasaki H, Shimizu Y. Trend of coronary heart disease and its relationship to risk factors in a Japanese population: A 26-year follow-up, Hiroshima/Nagasaki study. Jpn Circ J 1990; 54: 414-421. PMID: 2398621 101. Konishi M, Iso H, Iida M, et al. Trends for coronary heart disease and its risk factors in Japan: Epidemiologic and pathologic studies. Jpn Circ J 1990; 54: 428-435. PMID: 2398623 102. Wakugami K, Iseki K, Kimura Y, et al. Relationship between serum cholesterol and the risk of acute myocardial infarction in a screened cohort in Okinawa, Japan. Jpn Circ J 1998; 62: 7-14. PMID: 9559412 103. Kitamura A, Iso H, Naito Y, et al. High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation 1994; 89: 2533-2539. PMID: 8205661 104. Okamura T, Tanaka H, Miyamatsu N, et al. NIPPON DATA80 Research Group. The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort. Atherosclerosis 2007; 190: 216-223. PMID: 16529754 105. Tanabe N, Iso H, Okada K, et al. Japan Arteriosclerosis Longitudinal Study Group. Serum total and non-high-density lipoprotein cholesterol and the risk prediction of cardiovascular events ―The JALS-ECC. Circ J 2010; 74: 1346-1356. PMID: 20526038 106. Sugiyama D, Okamura T, Watanabe M, et al. NIPPON DATA 80/90 Research Group. Risk of hypercholesterolemia for cardiovascular disease and the population attributable fraction in a 24-year Japanese cohort study. J Atheroscler Thromb 2015; 22: 95-107. PMID: 25185893 107. Kitamura A, Noda H, Nakamura M, et al. Association between

non-high-density lipoprotein cholesterol levels and the incidence of coronary heart disease among Japanese: The Circulatory Risk in Communities Study (CIRCS). J Atheroscler Thromb 2011; 18: 454- 463. PMID: 21378473 108. Imamura T, Doi Y, Ninomiya T, et al. Non-high-density lipoprotein

cholesterol and the development of coronary heart disease and stroke subtypes in a general Japanese population: The Hisayama Study. Atherosclerosis 2014; 233: 343-348. PMID: 24530960 109. Tanaka F, Makita S, Onoda T, et al. Iwate-Kenco Study Group. Predictive value of lipoprotein indices for residual risk of acute myocardial infarction and sudden death in men with low-density lipoprotein cholesterol levels <120 mg/dl. Am J Cardiol 2013; 112: 1063-1068. PMID: 23831165 110. Saito I, Yamagishi K, Kokubo Y, et al. Non-High-Density Lipoprotein Cholesterol and Risk of Stroke Subtypes and Coronary Heart Disease: The Japan Public Health Center-Based Prospective (JPHC) Study. J Atheroscler Thromb 2020; 27: 363-374. PMID: 31534078 111. Takeuchi T, Nemoto K, Takahashi O, et al. Comparison of cardiovascular disease risk associated with 3 lipid measures in Japanese adults. J Clin Lipidol 2014; 8: 501-509. PMID: 25234563 112. Saiki Y, Otsuka T, Kato K, et al. A Proposal for the Optimal Management Target for Serum Non-High-Density Lipoprotein Cholesterol Level in Low-Risk Japanese Workers. J Atheroscler Thromb 2016; 23: 422-430. PMID: 26875520 113. Kuwabara K, Harada S, Sugiyama D, et al. Relationship between Non-High-Density Lipoprotein Cholesterol and Low-Density Lipoprotein Cholesterol in the General Population: the KOBE Study and Tsuruoka Metabolomic Cohort Study. J Atheroscler Thromb 2016; 23: 477-490. PMID: 26961218 114. Masuda D, Yamashita S. Postprandial Hyperlipidemia and Remnant Lipoproteins. J Atheroscler Thromb 2017; 24: 95-109. PMID: 27829582 115. Saito I, Iso H, Kokubo Y, et al. Metabolic syndrome and all-cause and cardiovascular disease mortality: Japan Public Health Center-based Prospective (JPHC) Study. Circ J 2009; 73: 878-884. PMID: 19282609 116. Noda H, Iso H, Saito I, et al. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study. Hypertens Res 2009; 32: 289-298. PMID: 19262490 117. Tsukinoki R, Okamura T, Watanabe M, et al. Blood pressure, low-density lipoprotein cholesterol, and incidences of coronary artery disease and ischemic stroke in Japanese: The Suita study. Am J Hypertens 2014; 27: 1362-1369. PMID: 24713850 118. Pischon T, Girman CJ, Sacks FM, et al. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation 2005; 112: 3375-3383. PMID: 16316964 119. Usui T, Nagata M, Hata J, et al. Serum Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease in Community Dwellers with Chronic Kidney Disease: the Hisayama Study. J Atheroscler Thromb 2017; 24: 706-715. PMID: 27840387 120. Okamura T, Hayakawa T, Kadowaki T, et al. NIPPON DATA90 Research Group. The inverse relationship between serum high-density lipoprotein cholesterol level and all-cause mortality in a 9.6-year follow-up study in the Japanese general population. Atherosclerosis 2006; 184: 143-150. PMID: 15913635 121. Iso H, Sato S, Kitamura A, et al. Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke 2007; 38: 1744-1751. PMID: 17431205 122. Satoh H, Tomita K, Fujii S, et al. Lower high-density lipoprotein cholesterol is a significant and independent risk for coronary artery disease in Japanese men. J Atheroscler Thromb 2009; 16: 792-798. PMID: 20032587 123. Hirata T, Sugiyama D, Nagasawa SY, et al. Evidence for Cardiovascular Prevention from Observational Cohorts in Japan (EPOCH-JAPAN) Research Group. A pooled analysis of the association of isolated low levels of high-density lipoprotein cholesterol with cardiovascular mortality in Japan. Eur J Epidemiol 2017; 32: 547-557. PMID: 27709448 124. Watanabe J, Kakehi E, Kotani K, et al. Isolated low levels of high-density lipoprotein cholesterol and stroke incidence: JMS Cohort Study. J Clin Lab Anal 2020; 34: e23087. PMID: 31742753 125. Hirata A, Okamura T, Sugiyama D, et al. NIPPON DATA90 Research Group. The Relationship between Very High Levels of Serum High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in a 20-Year Follow-Up Study of Japanese General Population. J Atheroscler Thromb 2016; 23: 800-809. PMID: 26923252 126. Castelli WP. Lipids, risk factors and ischaemic heart disease. Atherosclerosis 1996; 124 Suppl: S1-S9. PMID: 8831910 127. Sarwar N, Danesh J, Eiriksdottir G, et al. Triglycerides and the risk of

coronary heart disease: 10,158 incident cases among 262,525 partici-